Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Arrowhead Research
ARWR
$12.6B
| $21.4M | 0.01% |
321,833
-28,406
| -8% | -$1.39M |
|
1227
CALL
Brinker International
EAT
$9.49B
| $21.3M | 0.01% |
+148,400
| New | +$19.4M |
|
1228
UMB Financial
UMBF
$11.2B
| $21.3M | 0.01% |
184,957
+12,158
| +7% | +$1.38M |
|
|
SAIL
1229
SailPoint Inc
SAIL
$10.8B
| $21.3M | 0.01% |
1,050,880
+461,686
| +78% | +$9.62M |
|
1230
PUT
Alcoa
AA
$14.3B
| $21.2M | 0.01% |
398,700
+134,900
| +51% | +$5.52M |
|
1231
Essential Utilities
WTRG
$11.4B
| $21.1M | 0.01% |
549,408
-96,107
| -15% | -$3.78M |
|
1232
Sterling Infrastructure
STRL
$16.3B
| $21M | 0.01% |
68,527
+23,713
| +53% | +$8.17M |
|
1233
Royalty Pharma
RPRX
$25.7B
| $20.9M | 0.01% |
542,064
-10,495
| -2% | -$400K |
|
1234
Solventum
SOLV
$14.3B
| $20.9M | 0.01% |
263,385
-76,202
| -22% | -$5.84M |
|
1235
CALL
Synchrony
SYF
$25.5B
| $20.9M | 0.01% |
250,000
+230,000
| +1,150% | +$17.6M |
|
1236
Paycom
PAYC
$9.57B
| $20.8M | 0.01% |
130,583
+20,392
| +19% | +$3.61M |
|
1237
PUT
Fastenal
FAST
$60.1B
| $20.8M | 0.01% |
518,000
| – | – |
|
1238
G-III Apparel Group
GIII
$1.44B
| $20.8M | 0.01% |
717,607
+251,502
| +54% | +$7.18M |
|
|
SEI
1239
CALL
Solaris Energy Infrastructure
SEI
$3.87B
| $20.7M | 0.01% |
+450,000
| New | +$21.8M |
|
1240
Sun Life Financial
SLF
$44.6B
| $20.7M | 0.01% |
331,330
+304,574
| +1,138% | +$18.4M |
|
|
SOBO
1241
South Bow Corp
SOBO
$7.57B
| $20.6M | ﹤0.01% |
748,859
-29,567
| -4% | -$803K |
|
1242
Albertsons Companies
ACI
$5.95B
| $20.6M | ﹤0.01% |
1,198,065
+7,602
| +0.6% | +$136K |
|
1243
NETSCOUT
NTCT
$2.81B
| $20.5M | ﹤0.01% |
758,630
+35,831
| +5% | +$969K |
|
1244
Shake Shack
SHAK
$2.9B
| $20.5M | ﹤0.01% |
252,063
-103,733
| -29% | -$9.15M |
|
1245
monday.com
MNDY
$3.7B
| $20.5M | ﹤0.01% |
138,633
+16,154
| +13% | +$2.72M |
|
1246
PUT
MasTec
MTZ
$21.9B
| $20.4M | ﹤0.01% |
+94,000
| New | +$19.7M |
|
1247
Vale
VALE
$60.9B
| $20.3M | ﹤0.01% |
1,561,385
-997,785
| -39% | -$12.1M |
|
1248
CALL
ASML
ASML
$691B
| $20.3M | ﹤0.01% |
19,000
+10,600
| +126% | +$11.1M |
|
1249
CALL
Parker-Hannifin
PH
$134B
| $20.3M | ﹤0.01% |
23,100
-29,100
| -56% | -$23.8M |
|
1250
Alexandria Real Estate Equities
ARE
$8.28B
| $20.3M | ﹤0.01% |
414,392
+27,675
| +7% | +$1.63M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.